François Genêt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
François Genêt has a total of 222 co-authors. Here are the top co-authors by number of shared publications:
Marjorie Salga
UPOH (Unité Péri Opératoire du Handicap, Perioperative Disability Unit), Department of PMR « Suivi au long cours », Raymond-Poincaré Hospital, GHU Paris-Saclay, Assistance Publique – Hôpitaux de Paris (AP-HP), Garches, France; Versailles Saint-Quentin-en-Yvelines University (UVSQ - Paris Saclay University), UR 20262 Handistart, UFR Simone Veil Santé, Montigny le Bretonneux, France
4 shared publicationsAlexis Schnitzler
Université Paris, INSERM U1153- CRESS EpiAgeing, Paris, France
3 shared publicationsLaure Gatin
Université Paris SaclayU1179 END:ICAP HandiResp EA4047, Paris, France
3 shared publications- Marjorie Salga
UPOH (Unité Péri Opératoire du Handicap, Perioperative Disability Unit), Physical and Rehabilitation Medicine Department, Raymond-Poincaré Hospital, Assistance Publique—Hôpitaux de Paris (AP-HP), 92380 Garches, France
3 shared publications Philippe Denormandie
Université Paris SaclayU1179 END:ICAP HandiResp EA4047, Paris, France
3 shared publications- Romain David
CHU de Poitiers, PRISMATICS Lab (Predictive Research in Spine/Neuromodulation Management and Thoracic Innovation/Cardiac Surgery), 86000 Poitiers, France
3 shared publications
Latest Publications
- 2 July 2026
- Published by Wolters Kluwer Health in American Journal of Physical Medicine & Rehabilitation
- Vol. 105 (11S) , S926-S931
Redefining Spasticity
Inconsistent and variably interpreted definitions of spasticity, alongside evolving mechanistic understanding, highlight the need for a clear, clinically relevant consensus definition. An international expert panel used a modified Delphi process to develop a concise, clinically applicable definition that reflects current understanding and supports consistent assessment and management. Participants reviewed existing definitions, completed a pre‑meeting survey, and engaged in structured discussions, with draft definitions iteratively refined through successive rounds of voting to achieve consensus. Key components identified included disordered sensorimotor control, central nervous system involvement, and velocity‑dependent and length‑dependent resistance to passive stretch, whereas existing definitions were considered either overly narrow or insufficiently relevant to clinical practice. The consensus definition characterizes spasticity as “A disorder of sensorimotor control resulting from upper motor neuron disease. It is characterized by velocity- and length-dependent involuntary muscle overactivity, which is intermittent or sustained, during passive stretch.” This definition integrates contemporary mechanistic concepts with clinical applicability and is intended to improve conceptual clarity, facilitate communication, and promote consistency in diagnosis, measurement, and treatment.
- 2 July 2026
- Published by Wolters Kluwer Health in American Journal of Physical Medicine & Rehabilitation
- Vol. 105 (11S) , S926-S931
Redefining Spasticity
Inconsistent and variably interpreted definitions of spasticity, alongside evolving mechanistic understanding, highlight the need for a clear, clinically relevant consensus definition. An international expert panel used a modified Delphi process to develop a concise, clinically applicable definition that reflects current understanding and supports consistent assessment and management. Participants reviewed existing definitions, completed a pre‑meeting survey, and engaged in structured discussions, with draft definitions iteratively refined through successive rounds of voting to achieve consensus. Key components identified included disordered sensorimotor control, central nervous system involvement, and velocity‑dependent and length‑dependent resistance to passive stretch, whereas existing definitions were considered either overly narrow or insufficiently relevant to clinical practice. The consensus definition characterizes spasticity as “A disorder of sensorimotor control resulting from upper motor neuron disease. It is characterized by velocity- and length-dependent involuntary muscle overactivity, which is intermittent or sustained, during passive stretch.” This definition integrates contemporary mechanistic concepts with clinical applicability and is intended to improve conceptual clarity, facilitate communication, and promote consistency in diagnosis, measurement, and treatment.
- Open Access
- 2 July 2026
- Published by Medical Journals Sweden AB in Journal of Rehabilitation Medicine
- Vol. 58, jrm45077
Identification of spastic muscles involved in abnormal joint posture in patients with upper motor neuron syndrome: a narrative review
Few studies have specifically investigated which muscles are involved in abnormal joint posture (AJP) due to muscle spasticity and should therefore be targeted for botulinum toxin injections. This gap has significant implications for treatment efficiency, safety, health economics, and sustainable healthcare. A 2000 to 2025 (July) PubMed search identified 3,488 articles, but only 7 articles met the criteria for providing a method to determine the muscles involved in AJP due to muscle spasticity. Of these, just 2 have proposed how to measure each muscle contribution and only 1 focused on identifying the muscle actually responsible for the observed AJP. There are many strategies for determining the muscles involved in spasticity-related AJP, but they are primarily based on inference. They draw on clinical skills, which incorporate descriptive and functional anatomy, knowledge of different muscle and joint structures, simple rules of biomechanics, determination of the exact phase of the movement involved, consideration of compensatory AJP in these motor control deficient patterns, and, of course, the patient’s goals. Achieving the authors’ proposed objective would enable the standardization of clinical practices, confirm the effectiveness of treatments for spasticity, particularly botulinum toxin, and ensure that the correct dose is injected in the right muscle.
- 2 July 2026
- Published by Medical Journals Sweden AB in Journal of Rehabilitation Medicine
- Vol. 58, jrm45077
Open AccessIdentification of spastic muscles involved in abnormal joint posture in patients with upper motor neuron syndrome: a narrative review
Few studies have specifically investigated which muscles are involved in abnormal joint posture (AJP) due to muscle spasticity and should therefore be targeted for botulinum toxin injections. This gap has significant implications for treatment efficiency, safety, health economics, and sustainable healthcare. A 2000 to 2025 (July) PubMed search identified 3,488 articles, but only 7 articles met the criteria for providing a method to determine the muscles involved in AJP due to muscle spasticity. Of these, just 2 have proposed how to measure each muscle contribution and only 1 focused on identifying the muscle actually responsible for the observed AJP. There are many strategies for determining the muscles involved in spasticity-related AJP, but they are primarily based on inference. They draw on clinical skills, which incorporate descriptive and functional anatomy, knowledge of different muscle and joint structures, simple rules of biomechanics, determination of the exact phase of the movement involved, consideration of compensatory AJP in these motor control deficient patterns, and, of course, the patient’s goals. Achieving the authors’ proposed objective would enable the standardization of clinical practices, confirm the effectiveness of treatments for spasticity, particularly botulinum toxin, and ensure that the correct dose is injected in the right muscle.
- Open Access
- 16 December 2025
- Published by Galenos Yayinevi in Diagnostic and Interventional Radiology
- Vol. 32 (3) , 322-327
Preoperative arterial and venous embolization of heterotopic ossification of the hip: a case-control study
Preoperative arterial and venous embolization of heterotopic ossification of the hip: a case-control study - Diagnostic and Interventional Radiology
- 16 December 2025
- Published by Galenos Yayinevi in Diagnostic and Interventional Radiology
- Vol. 32 (3) , 322-327
Open AccessPreoperative arterial and venous embolization of heterotopic ossification of the hip: a case-control study
Preoperative arterial and venous embolization of heterotopic ossification of the hip: a case-control study - Diagnostic and Interventional Radiology
- Open Access
Pathways for Diagnosis and Multimodal Management, Including Botulinum Neurotoxin Therapy, in Shoulder Conditions Following Acquired Central Nervous System Lesions
There is limited published guidance available to help less experienced practitioners assess and manage shoulder conditions, including spasticity, after acquired central nervous system (CNS) lesions. To address this gap, 11 spasticity and dystonia experts convened in a 2023 meeting to build on existing guidance, provide consensus on best treatment practice, and develop expert recommendations to guide the diagnosis and treatment of complications of shoulder conditions following CNS lesions. Presentations by each expert on diagnosis and management were followed by discussion; consensus on assessment and treatment practices was identified and recommendations developed. The expert panel recommended an assessment approach structured using the following components: patient history, including interpretation of reported symptoms; observation of postures and pain responses; clinical examination with targeted tests for specific signs; diagnostic tests; and assessment of upper limb impairment, activity limitations, and participation restrictions. This assessment process and the recommended measures recognize the importance of identifying shoulder involvement in upper limb spasticity as part of the diagnostic process in shoulder conditions following CNS lesions. These recommendations provide a practical approach to diagnosis and treatment for clinicians who are less experienced in evaluating and treating such conditions, simplifying otherwise complicated clinical scenarios.
Open AccessPathways for Diagnosis and Multimodal Management, Including Botulinum Neurotoxin Therapy, in Shoulder Conditions Following Acquired Central Nervous System Lesions
There is limited published guidance available to help less experienced practitioners assess and manage shoulder conditions, including spasticity, after acquired central nervous system (CNS) lesions. To address this gap, 11 spasticity and dystonia experts convened in a 2023 meeting to build on existing guidance, provide consensus on best treatment practice, and develop expert recommendations to guide the diagnosis and treatment of complications of shoulder conditions following CNS lesions. Presentations by each expert on diagnosis and management were followed by discussion; consensus on assessment and treatment practices was identified and recommendations developed. The expert panel recommended an assessment approach structured using the following components: patient history, including interpretation of reported symptoms; observation of postures and pain responses; clinical examination with targeted tests for specific signs; diagnostic tests; and assessment of upper limb impairment, activity limitations, and participation restrictions. This assessment process and the recommended measures recognize the importance of identifying shoulder involvement in upper limb spasticity as part of the diagnostic process in shoulder conditions following CNS lesions. These recommendations provide a practical approach to diagnosis and treatment for clinicians who are less experienced in evaluating and treating such conditions, simplifying otherwise complicated clinical scenarios.
- Open Access
- 1 January 2024
- Published by Societe Francaise de Physiotherapie in European Rehabilitation Journal
- Vol. 4 (1) , 1-2
The ERPHAN research unit: pioneeringpluridisciplinary research in rehabilitation inFrance
Rehabilitation. Societe Française de Physiotherapie
- 1 January 2024
- Published by Societe Francaise de Physiotherapie in European Rehabilitation Journal
- Vol. 4 (1) , 1-2
Open AccessThe ERPHAN research unit: pioneeringpluridisciplinary research in rehabilitation inFrance
Rehabilitation. Societe Française de Physiotherapie
- 6 April 2023
- Published by Elsevier in Annals of Physical and Rehabilitation Medicine
- Vol. 66 (6) , 101736
Disability-related medication profiles of Paralympic athletes in the Tokyo 2020 French delegation
- 6 April 2023
- Published by Elsevier in Annals of Physical and Rehabilitation Medicine
- Vol. 66 (6) , 101736
Disability-related medication profiles of Paralympic athletes in the Tokyo 2020 French delegation
- 30 November 2022
- Published by Elsevier in Annals of Physical and Rehabilitation Medicine
- Vol. 66 (2) , 101690
Microinvasive percutaneous needle tenotomy, An alternative to open surgery to treat neurological foot deformities
- 30 November 2022
- Published by Elsevier in Annals of Physical and Rehabilitation Medicine
- Vol. 66 (2) , 101690
Microinvasive percutaneous needle tenotomy, An alternative to open surgery to treat neurological foot deformities
- 19 October 2022
- Published by Elsevier in Archives of Physical Medicine and Rehabilitation
- Vol. 104 (3) , 418-424
Accuracy of Resting Energy Expenditure Estimation Equations in Polio Survivors
- 19 October 2022
- Published by Elsevier in Archives of Physical Medicine and Rehabilitation
- Vol. 104 (3) , 418-424
Accuracy of Resting Energy Expenditure Estimation Equations in Polio Survivors